Adjuvant Chemoradiation for Pancreatic Adenocarcinoma: The Johns Hopkins Hospital—Mayo Clinic Collaborative Study

BACKGROUND: Survival for pancreatic ductal adenocarcinoma is low, the role of adjuvant therapy remains controversial, and recent data suggest adjuvant chemoradiation (CRT) may decrease survival compared with surgery alone. Our goal was to examine efficacy of adjuvant CRT in resected pancreatic adeno...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hsu, Charles C., Herman, Joseph M., Corsini, Michele M., Winter, Jordan M., Callister, Matthew D., Haddock, Michael G., Cameron, John L., Pawlik, Timothy M., Schulick, Richard D., Wolfgang, Christopher L., Laheru, Daniel A., Farnell, Michael B., Swartz, Michael J., Gunderson, Leonard L., Miller, Robert C.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Springer-Verlag 2010
Schlagworte:
Pancreatic Tumors
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2840672/
https://ncbi.nlm.nih.gov/pubmed/20087786
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-009-0743-7
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge